However, a severe bleeding phenotype rather than factor levels is becoming increasingly recognized as an indication for prophylactic treatment [1] because those with baseline endogenous FVIII levels associated with mild and moderate hemophilia A can still experience joint bleeds and develop significant arthropathy [5]. Here, F8 is linked to hemophilia A.